Infectious agent detection by nucleic acid (dna or rna); hepatitis c, screening, amplified probe technique
Code effective Jun 27, 2024
HCPCS Section
Procedures/Professional Services (Temporary Codes)
G0567 is a valid 2026 HCPCS code meaning Infectious agent detection by nucleic acid (dna or rna); hepatitis c, screening, amplified probe technique or (Screening hep c detect) for short. HCPCS G0567 has been effective since 06/27/2024 and applies to Diagnostic laboratory.
|
HCPCS Level II Code Section G - Procedures/Professional Services (Temporary Codes) |
|
| HCPCS Code | G0567 |
|---|---|
| Description |
Long description:
Short description: |
| HCPCS Pricing indicator |
13 - Clinical Lab Fee Schedule - Price established by carriers (e.g., not otherwise classified, individual determination, carrier discretion)
|
| Multiple pricing indicator |
A - Not applicable as HCPCS priced under one methodology
|
| Coverage code | C - Carrier judgment |
| BETOS2 code | T1H - Lab tests - other (non-Medicare fee schedule) |
| HCPCS Action code | N - No maintenance for this code |
| Type of service | 5 - Diagnostic laboratory |
| Effective date | Effective Jun 27, 2024 |
| Date added | Added Jun 27, 2024 |
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026
CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.